初级胆道胆道炎:分子病变的前景和自然产品的治疗潜力
Yanling Zhao1, Shizhang Wei2, Lisheng Chen1,3
1Department of Pharmacy, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Frontiers in immunology
|July 17, 2023
概括
原发性胆道硬化 (PBC) 是一种慢性肝病. 需要新的多向药物,因为目前的PBC治疗方法不足,特别是对不响应的患者.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 原发性胆道硬化 (PBC) 是一种慢性胆固醇性免疫性肝病,具有复杂的发病因子.
- 研究已经对胆汁酸代谢,肠道微生物群和PBC中的自身免疫反应有了更深入的了解.
- 准确的PBC病理机制仍然不完全理解.
研究的目的:
- 在过去的20年中,审查PBC的病理机制.
- 讨论PBC药物研发的最新进展.
- 突出目前PBC治疗策略中未得到满足的需求.
主要方法:
- 临床和实验室研究PBC病变的文献综述.
- 对PBC药物发现和开发最近20年的研究分析.
- 评估当前的治疗选择及其局限性.
主要成果:
- 尽管取得了进展,但PBC的发病因子尚未完全阐明.
- 目前的治疗方法和症状药物支持对于许多PBC患者来说是不够的.
- 新兴药物候选药物表现出混合的成功,单一向药物缺乏理想的疗效.
结论:
- 对于原发性胆汁硬化,迫切需要新的治疗策略.
- 多向药物开发是有效治疗PBC的未来趋势.
- 解决当前治疗方法的局限性对于改善患者的治疗结果至关重要.
相关概念视频
Chronic Bowel Disorders: Introduction
489
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
Inflammatory Bowel Disease IV: Pharmacological Management
154
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
154
Chronic Pancreatitis I: Introduction
116
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
116
Hepatic Drug Excretion: Influencing Factors
158
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
158
Chronic Pancreatitis II: Collaborative Care
115
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
115
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
175
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
175


